Company Data

Atossa Therapeutics Inc.

Ticker
ATOS
Current Price
$0.8132 -3.13%
Market Cap
$105.0M
Price Target
Refer to Report
Volume
429.6K
52wk Range
$0.5526 - $1.66
Advanced Market Data

Overview

Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company’s drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy